M. Bélanger

发表

Plasma interleukin‐18 (IL‐18) levels are correlated with antioxidant vitamin coenzyme Q10 in preeclampsia

P. Julien, L. Roland, A. Gagné, 2010, Acta obstetricia et gynecologica Scandinavica.

Gabapentin: long-term antianxiety and hypnotic effects in psychiatric patients with comorbid anxiety-related disorders.

L. Beauclair, G. Chouinard, M. Bélanger, 1998, Canadian journal of psychiatry. Revue canadienne de psychiatrie.

Plasma lipoprotein profile in the male cynomolgus monkey under normal, hypogonadal, and combined androgen blockade conditions.

C. Labrie, P. Julien, A. Tchernof, 2004, The Journal of clinical endocrinology and metabolism.

Seasonal mercury exposure and oxidant-antioxidant status of James Bay sport fishermen.

P. Julien, É. Dewailly, M. Mirault, 2008, Metabolism: clinical and experimental.

Dietary contaminants and oxidative stress in Inuit of Nunavik.

P. Julien, É. Dewailly, M. Mirault, 2006, Metabolism: clinical and experimental.

Therapeutic Tolerance and Rebound Psychosis During Quetiapine Maintenance Monotherapy in Patients With Schizophrenia and Schizoaffective Disorder

L. Beauclair, G. Chouinard, H. Margolese, 2002, Journal of clinical psychopharmacology.

Potentiation of fluoxetine by aminoglutethimide, an adrenal steroid suppressant. in obsessive-compulsive disorder resistant to ssris: A case report

L. Beauclair, G. Chouinard, M. Bélanger, 1996, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

Reassessing the interpretation of oxidation–reduction potential in male infertility

M. Bélanger, M. Benkhalifa, J. Lamoureux, 2022, Reproduction & fertility.

Environmental contaminants and redox status of coenzyme Q10 and vitamin E in Inuit from Nunavik.

P. Julien, É. Dewailly, M. Mirault, 2008, Metabolism: clinical and experimental.

Existence of Compensatory Defense Mechanisms Against Oxidative Stress and Hypertension in Preeclampsia

W. Fraser, P. Julien, L. Roland, 2010, Hypertension in pregnancy.

Tryptophan in the treatment of late luteal phase dysphoric disorder: a pilot study.

S. Young, L. Annable, M. Bélanger, 1994, Journal of psychiatry & neuroscience : JPN.

Endometrium Immunomodulation to Prevent Recurrent Implantation Failure in Assisted Reproductive Technology

D. Montjean, M. Bélanger, M. Benkhalifa, 2022, International journal of molecular sciences.

Therapeutic tolerance to quetiapine: Response to Drs. Goldstein and Macfadden

L. Beauclair, G. Chouinard, H. Margolese, 2004 .

Risperidone and clozapine in the treatment of drug-resistant schizophrenia and neuroleptic-induced supersensitivity psychosis

Robert Miller, G. Chouinard, M. Bélanger, 1994, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

Estimating glomerular filtration rate in patients with acute kidney injury: a prospective multicenter study of diagnostic accuracy.

J. Cailhier, J. Bouchard, M. Bélanger, 2019, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Effects of discontinuing anticholinergic treatment on movement disorders, cognition and psychopathology in patients with schizophrenia

L. Beauclair, H. Margolese, J. Desmarais, 2014, Therapeutic advances in psychopharmacology.

An Overview of E-Cigarette Impact on Reproductive Health

D. Montjean, M. Bélanger, M. Benkhalifa, 2023, Life.

Omega-3 fatty acid prevents heart rate variability reductions associated with particulate matter.

I. Romieu, M. Lazo, P. Julien, 2005, American journal of respiratory and critical care medicine.

A cross-sectional study of parkinsonism and tardive dyskinesia in lithium-treated affective disordered patients.

G. Chouinard, A. Ghadirian, L. Annable, 1996, The Journal of clinical psychiatry.

Lithium, benzodiazepines, and sexual function in bipolar patients.

A. Ghadirian, L. Annable, M. Bélanger, 1992, The American journal of psychiatry.

A Canadian multicenter, double-blind study of paroxetine and fluoxetine in major depressive disorder.

R. Remick, A. Ravindran, L. Beauclair, 1999, Journal of affective disorders.

An early Phase II clinical trial with followup of tomoxetine (LY139603) in the treatment of newly admitted depressed patients.

B. Jones, G. Chouinard, J. Bradwejn, 1985, Psychopharmacology bulletin.

Technique for Injecting Long-Acting Neuroleptics

G. Chouinard, M. Bélanger, 1982, British Journal of Psychiatry.

Hemocompatibility, biocompatibility, inflammatory and in vivo studies of primary reference materials low-density polyethylene and polydimethylsiloxane: a review.

M. Bélanger, Y. Marois, Y Marois, 2001, Journal of biomedical materials research.